Molbio Diagnostics shares made a strong D-Street debut on Monday, listing at a premium of 21% over their IPO price on both the BSE and NSE. The stock opened at Rs 980 apiece on both exchanges, up 21.44% from the issue price of Rs 807. The strong debut surpassed grey market expectations, which had indicated a listing premium of around 15%.
The Rs 939.70 crore IPO was priced at Rs 807 per share and comprised a fresh issue of 25 lakh shares worth Rs 200 crore and an offer for sale (OFS) of 92 lakh shares valued at Rs 739.70 crore.
